Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000921895-25-002032
Filing Date
2025-07-28
Accepted
2025-07-28 19:20:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3231
  Complete submission text file 0000921895-25-002032.txt   5108
Mailing Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121 858-369-7100
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 144 | Act: 33 | File No.: 001-41827 | Film No.: 251157066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248
Business Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248 214.866.0202
Anson Funds Management LP (Reporting) CIK: 0001491072 (see all company filings)

EIN.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 144